“HER2检测原则”经许可改编自“Wolff AC, Hammond MEH, Allison KH, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. ...
Footnote i revised: Patients with a known genetic predisposition to breast cancer may have an increased risk of contralateral or ipsilateral breast cancers after breast-conservation therapy.Risk reduction strategies including prophylactic mastectomies should be discus...
This page has been extensively revised based on the ASCO/CAP HER2 testing guideline. Principles of HER2 Testing, modified with permission from Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College...
This page has been extensively revised based on the ASCO/CAP HER2 testing guideline. Principles of HER2 Testing, modified with permission from Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College...
都应使用最新ASCO/CAP激素受体检测指南中概述的方法,通过ICH法进行激素受体(ER和PR)检测 (Allison KH, Hammond ME, Dowsett M. et al. Estrogen and progesterone receptor testing in breast cancer. American Society of Clinical Oncology/College of American Pathologists Guideline Update. Arch Pathol Lab Med...
the Breast Cancer Guideline 中 也没有提及髓样癌需不需要检测基因突变,这是因为这一组织类型是否真实或准确存在尚怀有重大的疑问-如果组织学诊断错误将带来有害的影响。 二、早期与转移性乳腺癌的手术治疗 肿瘤根治术+受累区域淋巴结清扫是治疗乳腺癌的中流砥柱。但还有一些富有争议、一些尚在研究中: -保乳术后...
NCCN Guideline with NCCNE vidence Blocks™ - Breast Cancer RiskReduction Version 1.2018 Breast Cancer Risk Reduction Version 1.2018 Lung Cancer Screening Version 3.2018 NCCN Guidelines for Supportive Care NCCN Framework for Resource Stratification - Palliative Care Version 1.2018 (Preliminary) ...
>>>2024年更新的 ESMO 转移性乳腺癌在线指南v. 1.1版(ESMO Metastatic Breast Cancer Living Guideline V. 1.1)将 SG 治疗 mTNBC 的 ESMO 临床获益量表(ESMO-MCBS)评分,由既往的 4 分调整为最高等级 5 分。 指南推荐是基于夯实的循证证据,未来 SG 向一线冲击 ...
NCCN Guideline with NCCNE vidence Blocks - Breast Cancer RiskReduction Version 1.2018 Breast Cancer Risk Reduction Version 1.2018 Lung Cancer Screening Version 3.2018 NCCN Guidelines for Supportive Care NCCN Framework for Resource Stratification - Palliative Care Version 1.2018 (Preliminary) ...
基于 ASCENT 研究中 SG 展现的健康相关生活质量(HRQoL)的显著改善结果,2024 年更新的 ESMO 转移性乳腺癌在线指南 v. 1.1 版(ESMO Metastatic Breast Cancer Living Guideline V. 1.1)[3]将 SG 治疗 mTNBC 的 ESMO 临床获益量表(ESMO-MCBS)评分,由既往的 4 分调整为最高等级 5 分,这也是目前 mTNBC 二线...